Formulation Design of Self-Microemulsifying Drug Delivery Systems for Improved Oral Bioavailability of Celecoxib

Marshall K. W., 1999, Am. J. Orthop., 28, 19

Krishnan K., Campbell S., Abdel-Rah, 2003, Curr. Drug Targets, 4, 45, 10.2174/1389450033347028

Kawamori T., El-Bayoumy K., Ji B. Y, 1998, Int. J. Oncol., 13, 29

10.1002/(SICI)1098-2744(199908)25:4<231::AID-MC1>3.3.CO;2-6

HARRIS R E, 2000, Cancer Res., 60, 2101

PAULSON S K, 2001, J. Pharmacol. Exp. Ther., 297, 638

7) Leonard F., Patricia M., WO 01/42222 A1 (2001).

10.1023/A:1016268311867

10.1021/js970300n

10.1016/S0378-5173(98)00054-4

10.1016/S0378-5173(00)00614-1

Itoh K., Tozuka Y., Oguchi T., Yama, 2002, Int. J. Pharm., 238, 153, 10.1016/S0378-5173(02)00085-6

10.1016/S0168-3659(00)00343-6

10.1016/0378-5173(96)04496-1

10.1016/S0168-3659(02)00050-0

Cooney G. F., Jeevanandam V., Choud, 1998, Transplantation, 30, 1892

10.1016/S0169-409X(01)00182-X

10.1016/S0169-409X(96)00490-5

10.1016/0378-5173(94)90271-2

Hauss J. D., 2002, Am. Pharm. Rev., 4, 43

21) Cornell J. A., &ldquo;Experiments with Mixtures,&rdquo; 3rd ed., Wiley, New York, 2001.

22) Nazzal S., Khan M. A., <i>AAPS Pharm. Sci. Tech.</i>, <b>3</b>, article 5, (2002).

Kawakami K., Yoshikawa T., 2001, Current Top Colloid Interface Sci., 4, 153

10.1016/S0168-3659(02)00049-4

10.1021/la962108r

1995, J. Phys. Chem., 99, 14778, 10.1021/j100040a030

Delgado-Charro M. B., Iglesias-Vila, 1995, Bull. Tech. Gattefosse, 88, 55

10.1023/A:1011067300397

Gasperlin M., Spiclin P., 2001, Scientia Pharmaceutica, 69, 157

10.1016/j.ijpharm.2003.10.037

10.1016/S0928-0987(01)00095-1

32) Guidance for industry: Waiver of <i>in vivo</i> bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system, Rockville, MD, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 2000.